Lymph node I and II - PowerPoint PPT Presentation

1 / 175
About This Presentation
Title:

Lymph node I and II

Description:

Lymph node I and II – PowerPoint PPT presentation

Number of Views:2518
Avg rating:3.0/5.0
Slides: 176
Provided by: AUERB
Category:
Tags: coif | lymph | node

less

Transcript and Presenter's Notes

Title: Lymph node I and II


1
Lymph node I and II
  • Aaron Auerbach M.D M.P.H

2
A copy of this lecture can be found at
  • http//www.afip.org/consultation/hemepath/

3
Lecture outline
  • Reactive lymph node
  • Small B cell lymphoma
  • Large B cell lymphoma
  • Hodgkin lymphoma
  • T cell lymphoma

4
Tingible body macrophages
5
CD20
CD3
6
Bcl-6
CD10
7
CD21
Bcl-2
8
IgD mantle zones
9
PATTERNS OF BENIGN LYMPHADENOPATHY
  • FOLLICULAR
  • Follicular Hyperplasia
  • Giant lymph node hyperplasia-hyaline vascular
    (Castleman disease)
  • Progressively transformed germinal centers
  • HIV-related lymphadenopathy
  • Rheumatoid lymphadenopathy
  • Syphilitic lymphadenopathy
  • PARACORTICAL
  • Viral infections, NOS
  • Post-vaccinial lymphadenitis
  • Infectious mononucleosis (Epstein-Barr virus)
  • Drug induced hypersensitivity
  • Angioimmunoblastic lymphadenopathy
  • Dermatopathic lymphadenitis
  • Histiocytic necrotizing lymphadenitis (K-F
    disease)
  • Systemic lupus erythematosus
  • SINUS PATTERN
  • Sinus histiocytosis
  • Langerhans cell histiocytosis (EG, H-X)?

10
FOLLICULAR PATTERN
11
(No Transcript)
12
Follicular hyperplasia VS Follicular lymphoma
  • --Polymorphic cells
  • --? mitosis
  • --Macrophages
  • --Bcl-2 (-) and t(1418)(-)
  • --Architecture preserved
  • --Variation in G.C.
  • --No back to back follicles
  • --Monotonous cells
  • -- ? mitosis
  • -- ? Macrophages absent
  • --Bcl-2 () and t(1418)()
  • --Architecture effaced
  • --Little variation in G.C.
  • --Back to back follicles

13
FL
FH
14
FH
FL
15
NEXT 5 SLIDESWHAT IS YOUR DIAGNOSIS?
16
Follicular hyperplasia
17
Multiple germinal centers in one follicle
18
(No Transcript)
19
(No Transcript)
20
Castleman lymphadenopathy
  • Mediastinal lesions
  • Regressed germinal centers
  • broad mantle zone, onion skin
  • dendritic reticulum cells
  • Interfollicular vascularitylollipop
  • HHV8
  • Mulitcentric Castleman disease worse prognosis
  • Multicentric Castleman disease assoc w POEMS
    (polyneuropathy, organomegaly, endocrinopathy,
    monoclonal gammopathy, and skin abnormalities)

21
HIV related lymphadenopathy
Three stages are seen Follicular hyperplasia
Follicular involution Lymphocyte depletion
22
HIV related lymphadenopathy, follicular
hyperplasia
23
HIV related lymphadenopathy, follicular involution
24
LYMPHOCYTE DEPLETION
Small lymph nodes with fibrosis,? Follicles, ?
FDC, Histiocytes with phagocytized RBC
25
Next 3 slides
26
Epithelioid histiocytes near GC
27
Monocytoid B-cell hyperplasia
28
WHAT IS YOUR DIFFERENTIAL DIAGNOSIS?
29
Follicular patternTOXOPLASMA LYMPHADENOPATHY
  • CLINICAL
  • Asymptomatic or fever, cervical lymph nodes
  • Organism Toxoplasma gondii

ARCHITECTURE/CYTOLOGY - Follicular hyperplasia
- Epithelioid histiocytes near GC - Monocytoid
B-cells in sinuses - Serology confirms diagnosis
30
Paracortical patternINFECTIOUS MONONUCLEOSIS
  • CLINICAL FEATURES
  • Usually self limited, usually cervical lymph
    nodes, teens presenting with infections

ARCHITECTURE /CYTOLOGY - Paracortical
proliferation of immunoblasts - Sinuses
distended by monocytoid B cells or immunoblasts
- Focal necrosis/apoptosis - Hodgkins-like
cells sometimes
- LMP() or EBER() - Diff dx DLBCL
31
(No Transcript)
32
(No Transcript)
33
CD30
LMP1
34
Acute IgM IgG VCA Heterophile Ab
(monospot)
react w sheep or horse RBC Remote IgG EBNA, IgG
VCA CD8 T cells stop EBV infected B cells
from circulating CD30
35
Paracortical patternDERMATOPATHIC
LYMPHADENOPATHY
  • CLINICAL
  • Chronic dermatoses may be present but the most
    florid reactions are seen with exfoliative
    dermatitis

ARCHITECTURE/CYTOLOGY - Paracortex expansion -
Many pale histiocytes, some with with melanin -
Langerhans cells and interdigitating reticular
cells
- Atypical T cell should be absent - Mycosis
Fungoides must be considered if confluence is
present
36
(No Transcript)
37
(No Transcript)
38
CD1a
S-100
Both IRCs and LCs stain for CD1a and S100
39
HISTIOCYTIC NECROTIZING LYMPHADENITIS
  • CLINICAL
  • Kikuchi-Fujimoto diseaseAsian, women, mean age
    30 years
  • Usually cervical lymph nodes
  • Serologic tests for organisms negative (CMV, EBV,
    Toxo.)
  • Self limiting disease
  • Forme fruste of SLE

ARCHITECTURE/CYTOLOGY - Necrosis with
karyorrhectic dust - Acute inflammation is
absent (polys and eos)
- Plasmacytoid monocytes, cresentic histiocytes
- No plasma cells, unlike SLE
40
(No Transcript)
41
Crescentic histiocytes
karyorrhexis
CD68
42
CAT SCRATCH LYMPHADENITIS
  • CLINICAL
  • Contact with cat
  • The offending organism is Bartonella henselae

ARCHITECTURE/CYTOLOGY Suppurative granulomas
(stellate abscesses) Neutrophils monocytoid
B-cell hyperplasia Granulomas can be seen
outside the L.N. Warthin-Starry and Brown-Hopps
stains
43
(No Transcript)
44
Warthin-Starry
45
WHAT IS YOUR DIAGNOSIS?
46
S-100
CD68
47
Rosai-Dorfmansinus histiocytosis with massive
lymphadenopathy
  • CLINICAL
  • Bilateral cervical lymph nodes in a teen with
    fever

ARCHITECTURE/CYTOLOGY Distended sinuses with
foamy histiocytes Emperipoiesis (inflam cells in
histiocytes) No erythroid phagocytosis
(hemophagocytic syndrome) S-100(), CD68(),
lysozyme ()
48
Hemophagocytic syndrome
Viruses, T-cell lymphoma, X-linked
syndrome, Erythrophagocytosis, viral inclusions
49
BACILLARY ANGIOMATOSIS
  • CLINICAL
  • Immunodeficient patients, lymph nodes draining
    skin lesion
  • Organism Bartonella henselae

ARCHITECTURE/CYTOLOGY Vascular nodular
parenchymal proliferation Amphophilic and
eosinophilic material Vascular spaces are lined
by plump endothelium Warthin-Starry stain shows
organisms
50
(No Transcript)
51
Vascular nodular parenchymal proliferation
Vascular spaces are lined by plump endothelium
52
Warthin-Starry
53
BA VS KS
  • - Plump endothelial cells
  • - Little atypia
  • - Pos for organisms
  • - HHV8 -
  • - Spindle shaped cells
  • - Slit shaped vessels
  • - More atypic, mitosis ()
  • - Neg for organism
  • - HHV8

54
Lecture outline
  • Reactive lymph node
  • Small B cell lymphoma
  • Large B cell lymphoma
  • Hodgkin lymphoma
  • T cell lymphoma

55
Morphology only, what is your diagnosis?
56
CLL/SLL DEFINITION
  • --A neoplasm of monomorphic small, round
    B-lymphocytes admixed with prolymphocytes and
    paraimmunoblasts forming pseudofollicles.

CLL/SLL makes up 6.7 of all lymphomas
Derived from data from the International Lymphoma
Study Group. Blood, Vol. 89 No. 11 (June 1),
1997 pp. 3909-3918
57
Pseudofollicles
  • Low magnification
  • Spherical structures
  • Pale staining
  • Poorly defined
  • Never surrounded by
  • mantle cell zone
  • High magnification
  • --Cells loosely packed together with
  • clear spaces often separating cells
  • --Prolymphocytes (cells with one centrally
  • placed prominent nucleolus)

58
Peripheral Blood
  • absolute lymphocytosis
  • prolymphocytes less than 10

Basket cells/smudge cells
59
Phenotyping
  • Positive Negative
  • CD20 --weak CD3
  • CD79a CD10
  • CD5 (85) Cyclin D1 (90)
  • CD23 (85)
  • CD43 (98)
  • CD11c
  • IgM
  • IgM and IgD
  • cIg (5)

Cant use just immuno. If you are wrong 15 of
the time you will be fired!!!
60
CLL is really two diseases!
Favorable CD38, Zap70 negative
Adverse CD38, Zap70 positive
Naïve B-cell
Post germinal center cell
61
Immunoglobulin Gene Mutations
  • IgH variable chain mutations normally occur
    during germinal center stage of B cell maturation
  • CD38 and ZAP70 are surrogate markers for IgH
    variable chain gene mutation status

62
B- CLL GENETICS
  • Normal
  • karyotype 50
  • Del(13q) 25 good px
  • Tri 12 30 atyp histology/poor px
  • Del(11q) 2 poor prognosis
  • Del(17p) 10 poor prognosis

63
What is your diagnosis?
64
Hairy Cell Leukemia (HCL)
  • Medium B cells w pale cytoplasm,
    oval/reniform/beanshaped nuclei
  • Pancytopenia, monocytopenia
  • Spleen morphology
  • Localized to red pulp w red pulp lakes
  • Inconspicuous white pulp
  • Bone marrow
  • Often subtle infiltrate, dispersed B cells wi
    pale cytoplasm, fried egg appearance
  • ? reticulin fibrosis with dry tap
  • Lymph node
  • Paracortical infiltrate with sparing of
    follicles.

65
HCL
66
Hairy cell leukemiathe bright one!
67
HCL
  • Phenotype
  • Bright CD11c, CD25, CD103,
  • Annexin A1, TRAP, DBA.44 positive
  • Treatment
  • High response rates to purine analogues, 2CDA NO
    CHOP

68
CLL
HCL
69
Hairy cell leukemia variant
  • Leukocytosis,
  • Presence of monocytes,
  • Prominent nucleoli like PLL
  • Missing CD25 or CD103
  • Resistant to HCL therapy
  • Poor prognosis
  • WHO 2008, these cases are not thought to be
    biologically related to HCL

70
FL
CD10
BCL-2
BCL-6
71
Follicular lymphoma
  • BCL-2 ?with grade with nearly 100 positive in
    grade 1 and 75 grade 3
  • BCL-2 often - in cutaneous follicular lymphoma
  • t (1418)(q32q21) present in 90 of FL leads to
    overexpress BCL2 protein
  • t (1418) not sufficient to diagnose FCL
  • detectable by PCR in some normal subjects
  • also found in 15-20 DLCBCL
  • PCR is limited based on variation in the
    breakpoint involving BCL2.
  • MBC and mcr breakpoints account for 70 of cases
  • FISH detects nearly all breakpoints

72
Mantle Cell lymphoma
  • Clinical
  • --Lymphomatous polyposis is mantle cell which
    studs the GI tract
  • Phenotype
  • CD20, CD5 (90), CD43, BCL-2,
  • and nuclear BCL-1 (80 cases)
  • Genotype
  • t (1114) with rearrangement and
  • over-expression of BCL-1 (cyclin D1, PRAD1)
  • 13q14 deletion and trisomy 12 frequent (yes,
    similar to CLL)

73
MCL
BCL-2
BCL-1
74
PCR T(1114)(q13q32)
75
FISH
BCL1 and IgH loci detected via FISH. Probe
signals are co-localized at translocation
breakpoints (arrows).
76
(No Transcript)
77
CD20
MCL
CD3
CD5
78
Marginal zone lymphoma
  • 1. Malignant
  • Monocytoid cells
  • Plasmacytoid cells
  • Dutcher bodies
  • Expanded\confluent marginal zones
  • Lymphoepithelial lesions
  • 2. Reactive
  • Reactive germinal centers may be
  • colonized by marginal zone cells

79
Marginal zones reactive and neoplastic
80
Follicular colonization
81
(No Transcript)
82
Intranuclear inclusion
83
Lymphoepithelial lesions
84
T(1118) MLT and API2 genes
  • t (1118) in 25-50 MALT
  • t(1118) not in primary nodal MZL
  • -- t(1118) not in MALT with DLBCL
  • t (1118) resistant to antibiotic therapy

85
PRECURSOR LESIONS
  • In gastric MZL H. pylori infection is 90
  • Sjogren syndrome44 fold increase
  • Hashimoto thyroiditis
  • Hepatitis C
  • Borrelia burgdorferi (Lyme dz), skin
  • Campylobacter jejuni, eye

86
WHO 2008 Waldenstrom macroglobulinemia
  • WM is defined as LPL with bone marrow involvement
    IgM monoclonal gammopathy of any concentration
  • IgM paraprotein without LPL is not WM
  • Level of IgM paraprotein is irrelevant

87
Lymphoplasmacytic lymphoma
  • Morphology--small B lymphocytes, plasmacytoid
    lymphocytes and plasma cells, Dutcher bodies
  • ClinicalHyperviscosity (30), Neuropathy (10),
    Cryoglobulinemia
  • Immuno--CD5-, CD10-, CD23-
  • Molecular--No recurrent abnormality
  • PAX5 translocation (t(914)) not seen

88
LPL
89
Lecture outline
  • Reactive lymph node
  • Small B cell lymphoma
  • Large B cell lymphoma
  • Hodgkin lymphoma
  • T cell lymphoma

90
What is your diagnosis?
91
Burkitt Lymphoma
3 CLINICAL VARIANTS
ENDEMIC
SPORADIC
IMMUNO SUPPRESSED
92
ENDEMIC BURKITT LYMPHOMA
Africa Children 4-7 y/o Male Malaria Jaw/faci
al bones 95 EBV
93
Sporadic Burkitt lymphoma
  • adult median 30 y.o.
  • 30-50 of childhood lymphomas
  • EBV positive cells in 30 of cases

94
(No Transcript)
95
(No Transcript)
96
Immunophenotype, molecular
  • Immuno
  • -Positive for CD20, CD10 bcl-6
  • -Ki-67 100 of cells
  • -Neg for bcl-2, or weakly in 20
  • Molecular
  • -T(814) IgH/myc
  • -T(28) myc/kappa
  • -T(822) myc/lambda

97
Factoids
  • Translocation involving MYC is highly
    characteristic but not specific for Burkitt
    lymphoma
  • No single parameter alone (ie morphology,
    genetics, IHC) can be used as the gold standard
    for the diagnosis of Burkitt lymphoma
  • A combination of several techniques is required
    for dx.
  • The 2008 WHO does not recognize atypical Burkitt
    lymphoma as a distinct entity.
  • Instead, it acknowledges that there are cases of
    Burkitt lymphoma with ?nuclear pleomorphism,
    which previously would have been called atypical
    Burkitt

98
This used to be a simplified topic
  • You have a nasty looking tumor that you think is
    lymphoma with dispersed cells and no gland
    formation, then
  • 1. You look at the size of the cellslarge
    lymphoid cells
  • 2. You get immuno (CD20) to prove there are B
    cells
  • 3. You can make a diagnosis of diffuse large B
    cell lymphoma

99
DLBCL
  • Other lymphomas of large B cells
  • -Primary mediastinal (thymic)
  • large B cell lymphoma
  • -Intravascular large B cell
  • lymphoma
  • -DLBCL associated w chronic
  • inflammation
  • -Lymphomatoid granulomatosis
  • -ALK-positive LBCL
  • -Plasmablastic lymphoma
  • -LBCL arising in HHV8
  • multicentric Castlemans
  • -Primary effusion lymphoma
  • Borderline cases
  • Discussed later
  • Common morphologic variant
  • -Centroblastic
  • -Immunoblastic
  • -Anaplastic
  • Molecular subgroups
  • -Germinal centre B cell like
  • -Activated B cell like
  • IHC subgroups
  • -CD5 DLBCL
  • -Germinal centre B cell like
  • -Non germinal centre B cell
  • like
  • Subtypes
  • -T cell/histiocyte-rich large B
  • cell lymphoma
  • -Primary DLBCL of the CNS
  • -Primary cutaneous DLBCL, leg
  • type
  • -EBV DLBCL of the elderly

100
Gene expression profiling identified 2 subgroups
of DLBCL
Alizadeh et al, Nature 2000 403 503-510
  • Germinal center like
  • Activated B cell

101
Subtypes of DLBCL
  • T cell/histiocyte-rich large B cell lymphoma
  • Primary DLBCL of the CNS
  • Primary cutaneous DLBCL, leg type
  • EBV DLBCL of the elderly

102
T cell/histiocyte-rich large B cell lymphoma
CD20
CD3
Large cells lt10 of total cellularity Can look
like centroblasts, immunoblasts, LH cells, RS
cells CD20, LCA, CD30/-, rare CD15, bcl-6,
bcl2/-
103
Primary cutaneous DLBCL, leg type
104
DLBCL, leg type
  • Old diagnosis for E.O.R.T.C.
  • New diagnosis from WHO
  • elderly females
  • Aggressive
  • Tx, combination chemotherapy
  • 5 year survival 55 (Blood, 2005)
  • Histology
  • Immunoblastic
  • Round cell morphology

Bcl-2
Bcl-6
Immunos -Strong bcl-2, unlike cutaneous
follicular lymphoma - MUM1/IRF, FOXP1, CD10
usually -, BCL-6,
105
Other lymphomas of large B cells
  • Primary mediastinal (thymic) LBC lymphoma
  • Intravascular large B cell lymphoma
  • DLBCL associated w chronic inflammation
  • Lymphomatoid granulomatosis
  • ALK-positive LBCL
  • Plasmablastic lymphoma
  • LBCL arising in HHV8 multicentric Castlemans
  • Primary effusion lymphoma

106
Mediastinal (thymic) Large B-cell Lymphoma
  • Clinical
  • B cell lymphoma in mediastinum
  • May have superior vena cava syndrome
  • 20-40 year old women

compartmentalizing fibrosis
Immunos/molecular Lack of surface immunoglobulin
by flow But IgH rearrangement by PCR B-cell
markers Bcl-2 and bcl-6 can be CD30 (80),
but weak CD15 only rarely MAL protein
B cells w ?clear cytoplasm
107
Lymphomatoid granulomatosis
  • Angiocentric and angiodiestructive
    lymphoproliferative dz of extranodal sites,
    composed of EBV B cells and reactive T cells.
  • Used to be thought of as a T cell lymphoma
  • Lung, brain, liver, kidney skin

108
LYG
EBER
CD79
109
Lecture outline
  • Reactive lymph node
  • Small B cell lymphoma
  • Large B cell lymphoma
  • Hodgkin lymphoma
  • T cell lymphoma

110
Hodgkin lymphoma
  • WHO classification
  • Nodular lymphocyte predominant
  • Classical
  • Nodular sclerosis
  • Mixed cellularity
  • Lymphocyte-rich
  • Lymphocyte-depleted

111
Nodular Lymphocyte Predominant Hodgkin lymphoma
L H cells with 1 large folded nucleus, and
scant cytoplasm (popcorn cells) Absence of PMNs
and eosinophils Progressive transformation of
germinal centers (PTGC) is associated
112
Immunophenotype
  • CD45, CD20, J-chain and EMA
  • CD3 and CD57 T-cells in background ring
    malignant cells
  • Nearly all cases are CD15 CD30 neg
  • Oct2 and BOB.1 consistently present whereas in
    classic HL one or both will be absent

113
PROGRESSIVE TRANSFORMATION OF GERMINAL CENTERS
- Large follicles (3-4 times normal) -
inward migration of perifollicular small B cells
and activated T cells into the germinal
centers - Absent L and H cells - May
proceed, follow or accompany NLPHD
114
Classic Hodgkin lymphoma
  • -- 95 of HL with bimodal age with
  • 15-35 year peak and 2nd peak late life
  • -- Mediastinal

115
Nodular Sclerosis Hodgkin lymphoma
  • CD30, CD15 (75-85) CD45 neg, LMP-1 and EBER
    variable, BSAP(PAX5)
  • RS cells in up to 40 of cases

116
Mixed cellularity Hodgkin lymphoma (MCHL)
Interfollicular growth pattern may be seen May
have interstitial fibrosis but no capsular
thickening or broad bands of collagen
fibrosis EBV-LMP- highest frequently-75 Mediastin
al involvement uncommon
117
Lymphocyte rich Hodgkin lymphoma
nodular growth pattern Regressed germinal
centers RS cells in mantle zone No eos PMNs in
background
118
Lecture outline
  • Reactive lymph node
  • Small B cell lymphoma
  • Large B cell lymphoma
  • Hodgkin lymphoma
  • T cell lymphoma

119
T CELL LYMPHOMA BY LOCATION
Peripheral T-cell lymphoma, NOS Angioimmunoblastic
T-cell lymphoma Anaplastic large cell lymphoma
Lymph node
Adult T-cell leukemia/lymphoma T-cell
prolymphocytic leukemia T-cell large granular
lymphocytic leukemia Aggressive NK-cell
leukemia T cell lymphoblastic lymphoma
Leukemia/bone marrow
Enteropathy-type T cell lymphoma Hepatosplenic
T-cell lymphoma Extranodal NK/T-cell lymphoma,
Nasal type Subcutaneous panniculitis-like T cell
lymphoma Gd cutaneous T cell lymphoma Mycosis
fungoides Primary cutaneous CD30 T cell LPD
Extranodal
120
PERIPHERAL T-CELL LYMPHOMA, NOS
  • T cell lymphoma in which cases do not better fit
    into a different category
  • HE
  • clear cytoplasm
  • Inflammatory background of eosinophils and
    epithelioid histiocytes
  • Lymphoepithelioid variant (Lennert lymphoma)

121
They typically show increased clear cytoplasm and
have eosinophils or plasma cells
122
(No Transcript)
123
AILT
Tubinal 1988, Siegert 1992, Paulier 1999
124
AILT
Arborizing blood vessels w PAS material
Follicular dendritic cells CD23 surround vessels
125
CD10 positive in T cells
CD3
CD10
126
EBER
CD20
CD3
127
CXCL 13
  • Found in T cells in germinal centers
  • Expressed in follicular dendritic cells
  • PD1 also .

128
Step1 Distribution of tumor
Peripheral T-cell lymphoma, NOS Angioimmunoblastic
T-cell lymphoma Anaplastic large cell lymphoma
Lymph node
Adult T-cell leukemia/lymphoma T-cell
prolymphocytic leukemia T-cell large granular
lymphocytic leukemia Aggressive NK-cell
leukemia T cell lymphoblastic lymphoma
Leukemia/bone marrow
Enteropathy-type T cell lymphoma Hepatosplenic
T-cell lymphoma Extranodal NK/T-cell lymphoma,
Nasal type Subcutaneous panniculitis-like T cell
lymphoma Gd cutaneous T cell lymphoma Mycosis
fungoides Primary cutaneous CD30 T cell LPD
Extranodal
129
Anaplastic large cell lymphoma
  • Large cells with marked atypia
  • Hallmark cells are large kidney shaped nucleus
    with eosinophilic paranuclear area
  • Reed-Sternberg like cells, wreath-like
  • Multinucleate
  • Sinusoidal growth pattern
  • Show perivascular rosetting, but does not destroy
    blood vessels.

130
Anaplastic large cell lymphoma
Sinusoidal growth pattern
perivascular rosetting
Hallmark cells are large kidney shaped,
wreathlike nucleus
131
CD45
CD43
EMA
CD30
ALK-1
132
Translocations and fusion proteins involving ALK
Figure 7.
Stein, H. et al. Blood 2000963681-3695
NPM shuttles continuously between the cytoplasm
and nucleolus Cases with variant translocations
usually show ALK staining in the cytoplasm only
and are negative by PCR for NPM/ALK Therefore,
ALK immuno is a more sensitive diagnostic marker
than PCR
133
ALCL
  • ALCL is one of the T cell lymphomas that has the
    best responses to therapy. Alk has better px.
  • Except with the small cell variant. In small
    cell variant,
  • ALK positivity does not lead to a better
    prognosis.

134
ATLL Clinical syndrome
  • Caused by HTLV1
  • Japan, Caribbean, central Africa,
  • Lymphocytosis (62), lymphadenopathy (61), lytic
    bone lesions (36) HSM (61), skin lesions (61)
    hypercalcemia (73),
  • Large polylobated flower cells
  • Skin, epidermotropism w Pautrier-like
    microabscesses
  • Bone marrow, tumor cells ?osteoclasts
  • Dilated lymph node sinuses with tumor cells.
  • Variants
  • 1. Acute--leukemic
  • 2. Lymphomatous variantlymphadenopathy
  • 3. Chronic variantskin lesions
  • 4. Smoldering variant--WBC normal

135
Peripheral blood polylobated flower cell
Peripheral blood
Polylobated flower cell
skin
Lytic bone lesion
136
Bone tumor and osteoclasts
137
Phenotype
  • T cell markers, CD4, CD5,
  • HTLV1, FoxP3, CD25
  • EBV-
  • Cytotoxic markers -

138
Immunos
FoxP3
CD25
FoxP3
Pics from internet
139
Step1 Distribution of tumor
Peripheral T-cell lymphoma, NOS Angioimmunoblastic
T-cell lymphoma Anaplastic large cell lymphoma
Lymph node
Adult T-cell leukemia/lymphoma T-cell
prolymphocytic leukemia T-cell large granular
lymphocytic leukemia Aggressive NK-cell
leukemia T cell lymphoblastic lymphoma
Leukemia/bone marrow
Enteropathy-type T cell lymphoma Hepatosplenic
T-cell lymphoma Extranodal NK/T-cell lymphoma,
Nasal type Subcutaneous panniculitis-like T cell
lymphoma Gd cutaneous T cell lymphoma Mycosis
fungoides Primary cutaneous CD30 T cell LPD
Extranodal
140
Step1 Distribution of tumor
Peripheral T-cell lymphoma, NOS Angioimmunoblastic
T-cell lymphoma Anaplastic large cell lymphoma
Lymph node
Adult T-cell leukemia/lymphoma T-cell
prolymphocytic leukemia T-cell large granular
lymphocytic leukemia Aggressive NK-cell
leukemia T cell lymphoblastic lymphoma
Leukemia/bone marrow
Enteropathy-type T cell lymphoma Hepatosplenic
T-cell lymphoma Extranodal NK/T-cell lymphoma,
Nasal type Subcutaneous panniculitis-like T cell
lymphoma Gd cutaneous T cell lymphoma Mycosis
fungoides Primary cutaneous CD30 T cell LPD
Extranodal
141
Enteropathy - type T- cell lymphoma
  • Associated with gluten-sensitive enteropathy
    (celiac disease) but occurs less commonly
    without gluten-sensitive enteropathy
  • Jejunal involvement perforation common
  • Stomach and colon not commonly affected
  • Aggressive, death from multiple perforations

142
ETTCL-Morphology
  • 1. T cell lymphoma part
  • Mixture of small and large lymphocytes
  • A mass of lymphocytes
  • 2. Gluten sensitive enteropathy part
  • Intraepithelial T-cells in adjacent mucosa
  • Villous atrophy

143
Phenotype
  • T cell markers
  • CD8, but can also be negative
  • CD103
  • CD5-
  • CD30/-, CD56/-
  • Cytotoxic markers

144
T cell lymphoma part
Small cell variant
145
Gluten sensitive enteropathy part
CD3
146
Gluten sensitive enteropathy part, glands
CD3
CD2
CD8
147
CD7
CD56
Gluten sensitive enteropathy part glands
CD20
CD5
148
Step1 Distribution of tumor
Peripheral T-cell lymphoma, NOS Angioimmunoblastic
T-cell lymphoma Anaplastic large cell lymphoma
Lymph node
Adult T-cell leukemia/lymphoma T-cell
prolymphocytic leukemia T-cell large granular
lymphocytic leukemia Aggressive NK-cell
leukemia T cell lymphoblastic lymphoma
Leukemia/bone marrow
Enteropathy-type T cell lymphoma Hepatosplenic
T-cell lymphoma Extranodal NK/T-cell lymphoma,
Nasal type Subcutaneous panniculitis-like T cell
lymphoma Gd cutaneous T cell lymphoma Mycosis
fungoides Primary cutaneous CD30 T cell LPD
Extranodal
149
Hepatosplenic T cell lymphoma
  • Young men
  • Hepatosplenomegaly
  • Often no lymphadenopathy
  • Aggressive
  • T cells in sinusoids of liver and spleen.
  • Spares portal triads white pulp
  • Most commonly Gd cells-- TCRd1, ßF1-, Usually
    CD4-/CD8-, but can be CD4-/CD8, CD5-, Tia, but
    perforin
  • Iso 7q, trisomy 8

150
Hepato part sinusoidal infiltrates
151
Splenic part sinusoidal infiltrate
CD3
152
Bone marrow sinusoids
CD3
153
Step1 Distribution of tumor
Peripheral T-cell lymphoma, NOS Angioimmunoblastic
T-cell lymphoma Anaplastic large cell lymphoma
Lymph node
Adult T-cell leukemia/lymphoma T-cell
prolymphocytic leukemia T-cell large granular
lymphocytic leukemia Aggressive NK-cell
leukemia T cell lymphoblastic lymphoma
Leukemia/bone marrow
Enteropathy-type T cell lymphoma Hepatosplenic
T-cell lymphoma Extranodal NK/T-cell lymphoma,
Nasal type Subcutaneous panniculitis-like T cell
lymphoma Gd cutaneous T cell lymphoma Mycosis
fungoides Primary cutaneous CD30 T cell LPD
Extranodal
154
Extranodal NK/T-cell lymphoma, Nasal type
  • AKA polymorphic reticulosis, lethal midline
    granuloma, angiocentric lymphoma.
  • Young/Asian
  • Big midline facial tumor, but can be seen in
    other locations
  • Angiocentric with necrosis
  • Plasma cells, eos, macs
  • Hemophagocytosis
  • T cell markers, Surface CD3-, cytoplasmic CD3?
  • CD56, CD57, cytotoxic markers, EBV

155
Angiocentric
156
Tumor cells and necrosis
157
CD45
CD3?
CD43
CD56
TIA-1
EBER
158
Step1 Distribution of tumor
Peripheral T-cell lymphoma, NOS Angioimmunoblastic
T-cell lymphoma Anaplastic large cell lymphoma
Lymph node
Adult T-cell leukemia/lymphoma T-cell
prolymphocytic leukemia T-cell large granular
lymphocytic leukemia Aggressive NK-cell
leukemia T cell lymphoblastic lymphoma
Leukemia/bone marrow
Enteropathy-type T cell lymphoma Hepatosplenic
T-cell lymphoma Extranodal NK/T-cell lymphoma,
Nasal type Subcutaneous panniculitis-like T cell
lymphoma Gd cutaneous T cell lymphoma Mycosis
fungoides Primary cutaneous CD30 T cell LPD
Extranodal
159
Subcutaneous panniculitis-like T cell lymphoma
  • Aggressive T cell lymphoma
  • WHO distinguishes between aß and ?d
  • ?ß are included in SPLTCL
  • Gd are called cutaneous ?d T cell lymphoma
  • Lesions are confined to subcutis
  • Lymphocytes encircle fat lobules
  • Septum involvement is mild
  • Karyorrhexis and fat necrosis almost always
    present

160
SPLTCL
From internet
Low power
High power
161
Mycosis Fungoides
  • Clinical-Scaly erythematous rash that progresses
    from patches/plaques and may form a solid skin
    tumor
  • Disease has a long natural history, so patients
    may have non-specific infiltrates in the skin and
    rashes for years before diagnostic histology
    develops.
  • Morphology-lymphocytes w cerebriform nuclei in
    dermis with extension to epidermis
    (epidermotropism)
  • Pautrier abscesses are collections of malignant T
    cells in the epidermis
  • Halos
  • Dermal infiltratenon specific
  • Usually CD4, rarely CD8
  • USUALLY NO CYTOTOXIC FEATURES

162
Epidermotropism
Beware cases of spongiosis can also have
epidermotropism
163
Cerebriform nuclei
Cerebriform nucleiserpentine, folding
Lutzner et al, Blood
164
Sezary Sydrome
  • Exfoliative erythroderma, generalized
    lymphadeopathy and malignant (Sezary cells in the
    peripheral blood
  • Spares bm

165
(No Transcript)
166
Questions?
167
The following are some extra charts for your
board studies
168
T cell lymphoma molecular abnormalities
169
LYMPHOBLASTIC LYMPHOMA VS. MANTLE CELL LYMPHOMA
170
LBL VS BURKITT
171
TCRLB vs. Nodular LP Hodgkins
172
TCRLB vs. Classical Hodgkin
173
(No Transcript)
174
(No Transcript)
175
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com